(2R,5R)-5-hydroxy-piperidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-ethyl ester

Catalog No. :
ACBETX247
CAS No. :
869658-84-4
Molecular Formula :
C13H23NO5
Molecular Weight :
273.33

IUPAC Name:1-(tert-butyl) 2-ethyl (2R,5R)-5-hydroxypiperidine-1,2-dicarboxylate

(2R,5R)-5-hydroxy-piperidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-ethyl ester structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$209.00Login to see priceInquiryInquiry
250mg98%$418.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,5R)-5-hydroxy-piperidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-ethyl ester
IUPAC Name1-(tert-butyl) 2-ethyl (2R,5R)-5-hydroxypiperidine-1,2-dicarboxylate
MDL No.MFCD15071886
Molecular FormulaC13H23NO5
Molecular Weight273.33
SMILESO=C(N1[C@@H](C(OCC)=O)CC[C@@H](O)C1)OC(C)(C)C
InChI KeyQXPPPWXTNBWACT-NXEZZACHSA-N
Synonym1,2-Piperidinedicarboxylic acid, 5-hydroxy-, 1-(1,1-diMethylethyl) 2-ethyl ester, (2R,5R)-;(2R,5R)-5-hydroxy-piperidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-ethyl ester;1,2-Piperidinedicarboxylic acid, 5-hydroxy-, 1-(1,1-dimethylethyl) 2-ethyl ester…;1-(tert-Butyl) 2-ethyl (2R,5R)-5-hydroxypiperidine-1,2-dicarboxylate;Ethyl (2R,5R)-1-Boc-5-hydroxypiperidine-2-carboxylate
CAS No.869658-84-4

Synthetic Route by SureRoute

1. ACBETX247 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBETX247 route product structure diagram
    ACBETX247869658-84-4
Inquiry

2. ACBETX247 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACELGK843 route compound structure diagram
    ACELGK843917344-15-1 In Stock
  2. Then
  3. ACBETX247 route product structure diagram
    ACBETX247869658-84-4
Inquiry

Comments (0)